All Stories

  1. Asymptomatic Leukocytospermia and Assisted Reproductive Technology Outcomes: Reason for concern?
  2. Male Infertility: Diagnostic Approach – A Committee Opinion
  3. Managing obesity-related male infertility: insights from weight loss intervention
  4. Refining assisted reproductive technology strategy in nonobstructive azoospermia: synchrony, sperm quality, and oocyte availability
  5. Introduction: luteinizing hormone for life’s journey
  6. Socioeconomic shadows in sperm epigenetics: insights and opportunities
  7. Human chorionic gonadotropin‐based clinical treatments for infertile men with non‐obstructive azoospermia
  8. The role of luteinizing hormone activity in spermatogenesis: from physiology to clinical practice
  9. To the editor: understanding presperm retrieval hormonal treatment effectiveness in nonobstructive azoospermia through real-world evidence
  10. From Double Helix to Double Trouble: Sperm DNA Fragmentation Unveiled – A Reproductive Urologist Perspective (AUA Bruce Stewart Memorial Lecture – ASRM 2024)
  11. Clinical factors impacting microdissection testicular sperm extraction success in hypogonadal men with nonobstructive azoospermia
  12. Letter to the editor: minimum number of mature oocytes in in vitro fertilization needed to obtain at least one euploid blastocyst — reinventing the wheel?
  13. Letter to the Editor: Evaluating magnetic-activated cell sorting and testicular sperm aspiration in high sperm DNA fragmentation—significant methodological flaws in a recent RCT
  14. Non-Obstructive Azoospermia and Intracytoplasmic Sperm Injection: Unveiling the Chances of Success and Possible Consequences for Offspring
  15. Approaching treatment of male infertility: the APHRODITE criteria
  16. Eligibility for the medical therapy among men with non‐obstructive azoospermia—Findings from a multi‐centric cross‐sectional study
  17. APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function
  18. Prevalence and clinical implications of biochemical hypogonadism in patients with nonobstructive azoospermia undergoing infertility evaluation
  19. Being a non-native English speaker in science and medicine
  20. The Impact of Male Infertility Research on the International Brazilian Journal of Urology: An Associate Editor’s Overview
  21. Unraveling the Impact of Sperm DNA Fragmentation on Reproductive Outcomes
  22. Improving standard practices in studies using results from basic human semen examination
  23. The true natural cycle frozen embryo transfer - impact of patient and follicular phase characteristics on serum progesterone levels one day prior to warmed blastocyst transfer
  24. Male infertility
  25. Introducing the IBJU patient corner new section
  26. Towards infertility care on equal terms: a prime time for male infertility
  27. The Fischer protocol for assisted reproductive technology treatment: Real-world data experience comparing elective single versus double embryo transfer with or without comprehensive chromosome screening
  28. Exploring the potential impact of human papillomavirus on infertility and assisted reproductive technology outcomes
  29. Total fertilization failure after ICSI: insights into pathophysiology, diagnosis, and management through artificial oocyte activation
  30. Surgically retrieved spermatozoa for ICSI cycles in non‐azoospermic males with high sperm DNA fragmentation in semen
  31. Male infertility and gonadotropin treatment: What can we learn from real-world data?
  32. Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models
  33. Reply of the authors: Applying reasonable methodological and statistical methods in clinical data analysis
  34. Sperm Retrieval Techniques
  35. A drop in serum progesterone from oocyte pick-up +3 days to +5 days in fresh blastocyst transfer, using hCG-trigger and standard luteal support, is associated with lower ongoing pregnancy rates
  36. POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost-effectiveness insights from real-world data research
  37. COVID-19 and its treatments: lights and shadows on testicular function
  38. Risk of genetic and epigenetic alteration in children conceived following ART : Is it time to return to nature whenever possible?
  39. Assessment of mitochondrial DNA viability ratio in day-4 biopsied embryos as an add-in to select euploid embryos for single embryo transfer
  40. Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology
  41. Vitrified–warmed blastocyst transfer timing related to LH surge in true natural cycle and its impact on ongoing pregnancy rates
  42. Environmental disruptors and testicular cancer
  43. Is the term ‘non‐male factor’ evidence‐based?
  44. Microdissection TESE versus conventional TESE for men with nonobstructive azoospermia undergoing sperm retrieval
  45. Recombinant gonadotropin therapy to improve spermatogenesis in nonobstructive azoospermic patients – A proof of concept study
  46. Evolution of the World Health Organization semen analysis manual: where are we?
  47. Who cares about oligozoospermia when we have ICSI
  48. Contemporary Use of ICSI and Epigenetic Risks to Future Generations
  49. Impact of obesity on medically assisted reproductive treatments
  50. The LH surge and ovulation re-visited: a systematic review and meta-analysis and implications for true natural cycle frozen thawed embryo transfer
  51. In silico analysis of microRNA genes in azoospermia factor Y-chromosome microdeletions
  52. The negative impact of most relevant infections on fertility and assisted reproduction technology
  53. Pharmacogenomic Approach in Controlled Ovarian Stimulation: Time to Take the Plunge?
  54. Reliability of the sperm chromatin dispersion assay to evaluate sperm deoxyribonucleic acid damage in men with infertility
  55. The combined effect of lifestyle intervention and antioxidant therapy on sperm DNA fragmentation and seminal oxidative stress in IVF patients: a pilot study
  56. Best urological practices on testing and management of infertile men with abnormal sperm DNA fragmentation levels: the SFRAG guidelines
  57. Outcomes of SARS-CoV-2 infected pregnancies after medically assisted reproduction
  58. Effect of varicocelectomy on sperm deoxyribonucleic acid fragmentation rates in infertile men with clinical varicocele: a systematic review and meta-analysis
  59. Microdissection testicular sperm extraction (micro-TESE) in men with infertility due to nonobstructive azoospermia: summary of current literature
  60. Effects of mobile phone radiofrequency radiation on sperm quality
  61. Diagnosis and management of infertility due to ejaculatory duct obstruction: summary evidence
  62. Differential Diagnosis of Azoospermia in Men with Infertility
  63. Preparation of the Endometrium for Frozen Embryo Transfer: A Systematic Review
  64. Viral infections and implications for male reproductive health
  65. Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
  66. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients
  67. Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials
  68. Time has come to provide infertile men with an optimal fertility pathway
  69. SARS-CoV-2 and Multi-Organ damage – What men's health specialists should know about the COVID-19 pathophysiology
  70. Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus
  71. Effect of Dexamethasone Co-Treatment During Ovarian Stimulation in Women of Different Reproductive Age With Elevated Early Follicular Phase Progesterone Level: a Prospective Longitudinal Study
  72. Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients
  73. Intracytoplasmic sperm injection versus conventional IVF
  74. Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
  75. Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients
  76. What does a varicocele do to a man's fertility? There is much more than meets the eye
  77. The obesity paradox in varicocele – is the protective effect real?
  78. Seeking the elusive genes associated with varicocele: a step forward
  79. Predictive model to estimate the chances of successful sperm retrieval by testicular sperm aspiration in patients with nonobstructive azoospermia
  80. A Global Survey of Reproductive Specialists to Determine the Clinical Utility of Oxidative Stress Testing and Antioxidant Use in Male Infertility
  81. The POSEIDON stratification - moving from poor ovarian response to low prognosis
  82. Air quality in the clinical embryology laboratory: a mini-review
  83. Concise practice recommendations for the provision of andrological services and assisted reproductive technology for male infertility patients during the SARS-CoV-2 in Brazil
  84. Response: Commentary: A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing In Vitro Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator
  85. Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations
  86. Differential DNA methylation pattern and sperm quality in men with varicocele
  87. SARS‐CoV‐2 and its relationship with the genitourinary tract: Implications for male reproductive health in the context of COVID‐19 pandemic
  88. EFFECT OF PENTOXIFYLLINE SUPPLEMENTATION ROUTINELY ADDED TO SPERM SUSPENSIONS IMMEDIATELY BEFORE INTRACYTOPLASMIC SPERM INJECTION
  89. SPERM RETRIEVAL RATES BY MICRO-TESE VERSUS CONVENTIONAL TESE IN MEN WITH HISTOPATHOLOGY CONFIRMED NON-OBSTRUCTIVE AZOOSPERMIA: A SYSTEMATIC REVIEW
  90. STRONTIUM-INDUCED OOCYTE ACTIVATION IN NON-MALE FACTOR ICSI CYCLES AND ADVANCED MATERNAL AGE
  91. Role of diagnostic intracytoplasmic sperm injection (ICSI) in the management of genetically determined zona pellucida-free oocytes during in vitro fertilization: a case report
  92. Elective frozen embryo transfer (freeze-all): there seems to be no harm to transfer in the next immediate menstrual cycle
  93. Comparing four laboratory three-parent techniques to construct human aged non-surrounded nucleolus germinal vesicle oocytes: A case-control study
  94. Phospholipase C zeta and oocyte activation defects: moving toward the objective identification of patients eligible for artificial oocyte activation
  95. Predictors of surgical sperm retrieval in non-obstructive azoospermia: summary of current literature
  96. Diagnostic accuracy of physical examination compared with color Doppler ultrasound in the determination of varicocele diagnosis and grading: Impact of urologists’ experience
  97. SARS‐CoV‐2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services
  98. Sperm retrieval rates by micro-TESE versus conventional TESE in men with non-obstructive azoospermia—the assumption of independence in effect sizes might lead to misleading conclusions
  99. COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management
  100. Role of genetics and epigenetics in male infertility
  101. Monoamniotic twin pregnancy following the transfer of a single blastocyst resulting from intracytoplasmic sperm injection of a single oocyte: a case report
  102. Ovarian reserve tests: Are they only a quantitative measure?
  103. Are specialized sperm function tests clinically useful in planning assisted reproductive technology?
  104. Validation of ART Calculator for Predicting the Number of Metaphase II Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection
  105. When to pull the trigger in nonazoospermic infertile men undergoing intracytoplasmic sperm injection?
  106. Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
  107. An update on clinical and surgical interventions to reduce sperm DNA fragmentation in infertile men
  108. Extended indications for sperm retrieval: summary of current literature
  109. Oocyte quantity, as well as oocyte quality, plays a significant role for the cumulative live birth rate of a POSEIDON criteria patient
  110. The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
  111. Clinical utility of freeze-all approach in ART treatment: A mini-review
  112. Fresh versus frozen blastocyst transfer
  113. Management Strategies for POSEIDON Groups 3 and 4
  114. Social Media in the Urology Practice | Opinion: YES
  115. Blastocyst ploidy is not related to the number of embryos generated nor to the type of ovarian stimulation
  116. Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
  117. Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
  118. Clinical utility of sperm DNA damage in male infertility
  119. Hot topics in male infertility: an afterword
  120. Indications and outcomes of varicocele repair
  121. Male infertility and assisted reproductive technology
  122. Methods of surgical sperm extraction and implications for assisted reproductive technology success
  123. Paternal age and assisted reproductive technology: problem solver or trouble maker?
  124. Testicular sperm for intracytoplasmic sperm injection in non-azoospermic men: a paradigm shift
  125. Correction to: The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis
  126. A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator
  127. Hormonal stimulation of spermatogenesis: a new way to treat the infertile male with non-obstructive azoospermia?
  128. The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis
  129. The relationship among sperm global DNA methylation, telomere length, and DNA fragmentation in varicocele: a cross-sectional study of 20 cases
  130. A quality management approach to controlled ovarian stimulation in assisted reproductive technology: the "Fischer protocol"
  131. Estimation of age-dependent decrease in blastocyst euploidy by next generation sequencing: development of a novel prediction model
  132. Female infertility and assisted reproductive technology
  133. Freeze-all strategy in IVF/ICSI cycles: an update on clinical utility
  134. Hot topics in female infertility: an afterword
  135. Impact of Body Mass Index on female fertility and ART outcomes
  136. Interventions to Prevent Sperm DNA Damage Effects on Reproduction
  137. Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
  138. Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept
  139. Pharmacogenetic algorithm for individualized controlled ovarian stimulation in assisted reproductive technology cycles
  140. Protein supplementation intake for bodybuilding and resistance training may impact sperm quality of subfertile men undergoing fertility treatment: a pilot study
  141. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes
  142. Storage of sperm samples from males with azoospermia
  143. Reactive oxygen species-induced alterations in H19-Igf2 methylation patterns, seminal plasma metabolites, and semen quality
  144. Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker—The Follicle-To-Oocyte (FOI) Index
  145. Unexplained infertility
  146. Clinical, obstetrical and perinatal outcomes of freeze-all cycles: systematic review and meta-analysis of randomized controlled trials
  147. Effect of varicocele repair on sperm DNA fragmentation: a systematic review and meta-analysis
  148. Oxidative stress induced alterations in seminal plasma antioxidants, is there any association with Keap1 gene methylation in human spermatozoa
  149. Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
  150. Testicular versus ejaculated sperm should be used for intracytoplasmic sperm injection (ICSI) in cases of infertility associated with sperm DNA fragmentation | Opinion: Yes
  151. Proteomic Signatures of Sperm Mitochondria in Varicocele: Clinical Use as Biomarkers of Varicocele Associated Infertility
  152. Intracytoplasmic sperm injection for male infertility and consequences for offspring
  153. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis
  154. The ‘Big Freeze’: freeze-all should not be used for everyone
  155. Use of testicular sperm in nonazoospermic males
  156. Effect of varicocele repair on sperm DNA fragmentation: A systematic review
  157. Should a Couple with Failed In Vitro Fertilization or Intracytoplasmic Sperm Injection and Elevated Sperm DNA Fragmentation Use Testicular Sperm for the Next Cycle?
  158. Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles
  159. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review
  160. Effect of varicocele repair on sperm DNA fragmentation: a review
  161. Individualized controlled ovarian stimulation in expected poor-responders: an update
  162. Poor definition of poor-ovarian response results in misleading clinical recommendations
  163. Human sperm handling in intracytoplasmic sperm injection processes: In vitro studies on mouse oocyte activation, embryo development competence and sperm oxidation-reduction potential
  164. Use of Testicular Sperm for ICSI: Pro
  165. Response: Nitroblue tetrazolium (NBT) assay
  166. Use of testicular sperm for intracytoplasmic sperm injection in men with high sperm DNA fragmentation: a SWOT analysis
  167. Faculty of 1000 evaluation for Review: Diagnosis and impact of sperm DNA alterations in assisted reproduction.
  168. Association between promoter methylation of MLH1 and MSH2 and reactive oxygen species in oligozoospermic men-A pilot study
  169. REPLY BY THE AUTHORS: Re: Persistent Mullerian Duct Syndrome: a rare entity with a rare presentation in need of multidisciplinary management
  170. Reproductive outcomes of testicular versus ejaculated sperm for intracytoplasmic sperm injection among men with high levels of DNA fragmentation in semen: systematic review and meta-analysis
  171. A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis on the clinical utility of sperm DNA fragmentation testing in specific male infertility scenarios
  172. A single cut-off value of sperm DNA fragmentation testing does not fit all
  173. All-round approach in diagnosis
  174. An evidence-based perspective on the role of sperm chromatin integrity and sperm DNA fragmentation testing in male infertility
  175. Antioxidants for elevated sperm DNA fragmentation: a mini review
  176. Best practice statements are not intended to dictate an exclusive course of management
  177. Call for wider application of sperm DNA fragmentation test
  178. Clinical utility of sperm DNA fragmentation testing: concise practice recommendations
  179. Comparison of strategies to reduce sperm DNA fragmentation in couples undergoing ICSI
  180. Current limitation and future perspective of sperm DNA fragmentation tests
  181. Despite limitations, sperm DNA fragmentation testing provides unique information complementary to but distinct from semen analysis results
  182. Development of targeted therapeutic strategies and refinement of sperm DNA fragmentation testing
  183. Development of treatment strategies in men with vulnerable sperm
  184. Drawbacks of the current practice
  185. Elucidating the clinical indications of sperm DNA fragmentation in male infertility
  186. Expanding our understanding of clinical laboratory testing in male infertility patients
  187. Expanding treatment paradigm of high sperm DNA fragmentation
  188. From bench to clinic
  189. Frontiers in clinical andrology
  190. Further evidence supports the clinical utility of sperm DNA fragmentation testing in male infertility workup and assisted reproductive technology
  191. Future direction in sperm DNA fragmentation testing
  192. Implication of sperm processing during assisted reproduction on sperm DNA integrity
  193. Insights on the predictive accuracy of the sperm DNA fragmentation tests on male infertility
  194. Integrating surgical and clinical andrology is essential to improve the quality of care delivered to infertile couples
  195. Is National Institute of Clinical Excellence (NICE) guideline a nice guideline?
  196. It is high time for clinical application of sperm DNA fragmentation testing
  197. Live birth must be the primary reproductive endpoint in IVF/ICSI studies evaluating sperm DNA fragmentation testing
  198. More good than harm should be expected when Testi-ICSI is applied to oligozoospermic men with post-testicular sperm DNA fragmentation
  199. One of the many missing links between infertility and sperm DNA fragmentation
  200. Reactive oxygen species and sperm DNA fragmentation
  201. Restoration of fertility potential via targeted treatment approach
  202. Risk factors associated with sperm DNA fragmentation
  203. Sperm DNA fragmentation for the evaluation of male infertility: clinical algorithms
  204. Sperm DNA fragmentation in clinical practice
  205. Sperm DNA fragmentation test results reflect the overall quality of the whole semen specimen
  206. Sperm DNA fragmentation testing in patients with subclinical varicocele: is there any evidence?
  207. Sperm DNA fragmentation testing is on the right track
  208. Sperm DNA fragmentation testing is the safe and economical way to go
  209. Sperm DNA fragmentation testing reveals the overall quality of a semen sample
  210. Sperm DNA fragmentation testing: a cross sectional survey on current practices of fertility specialists
  211. Sperm DNA fragmentation: a key player in decision making
  212. Sperm DNA fragmentation: a rationale for its clinical utility
  213. Sperm DNA fragmentation: laboratory and clinical aspects
  214. Sperm DNA fragmentation: overcoming standardization obstacles
  215. Technical aspects of sperm DNA fragmentation testing, methods to select sperm with low DNA fragmentation, and usefulness of redox potential measurement in male infertility
  216. The Society for Translational Medicine: clinical practice guidelines for sperm DNA fragmentation testing in male infertility
  217. The complex nature of the sperm DNA damage process
  218. The correct interpretation of sperm DNA fragmentation test
  219. The debate on sperm DNA fragmentation test goes on
  220. The importance of quality control and quality assurance in SDF testing
  221. The missing piece in management of infertile couple—clinical andrology
  222. The price and value of sperm DNA fragmentation tests
  223. The problem of mixing ‘apples and oranges’ in meta-analytic studies
  224. The role of female factors in the management of sperm DNA fragmentation
  225. The value of sperm DNA fragmentation testing in real-life clinical presentations
  226. Understanding sperm DNA fragmentation
  227. Unraveling the utility and limitations of clinical practice guidelines
  228. Use of sperm DNA fragmentation testing and testicular sperm for intracytoplasmic sperm injection
  229. A meta analysis to study the effects of body mass index on sperm DNA fragmentation index in reproductive age men
  230. A meta- analysis to evaluate the effects of body mass index on reproductive hormones in men
  231. A meta-analysis to evaluate the effects of body mass index on sperm parameters in infertile men
  232. Editorial Comment: Antioxidant enzyme profile and lipid peroxidation products in semen samples of testicular germ cell tumor patients submitted to orchiectomy
  233. GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles—A Systematic PRISMA Review and Meta-analysis
  234. Multi-centre assessment of nitroblue tetrazolium reactivity in human semen as a potential marker of oxidative stress
  235. Ascorbic acid reduces redox potential in human spermatozoa subjected to heat-induced oxidative stress
  236. Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology
  237. Oxidative Stress in Human Reproduction
  238. Reply to Eugenio Ventimiglia, Montorsi Francesco, and Andrea Salonia's Letter to the Editor re: Reecha Sharma, Avi Harlev, Ashok Agarwal, Sandro C. Esteves. Cigarette Smoking and Semen Quality: A New Meta-analysis Examining the Effect of the 2010 World...
  239. POSEIDON’s stratification of ‘Low prognosis patients in ART”: The WHY, the WHAT, and the HOW
  240. Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios
  241. Persistent Mullerian Duct Syndrome: a rare entity with a rare presentation in need of multidisciplinary management
  242. Clean Room Technology in ART Clinics
  243. Management of Infertile Men with Nonobstructive Azoospermia due to Spermatogenic Failure
  244. Reply from Authors re: Christian Leiber, Ulrich Wetterauer. The Cigarette and the Sperm: A Fatal Liaison? Eur Urol 2016;70:646–7
  245. Cigarette Smoking and Semen Quality: A New Meta-analysis Examining the Effect of the 2010 World Health Organization Laboratory Methods for the Examination of Human Semen
  246. A missing vas deferens: practical implications for urologists performing vasectomies and managing infertile men
  247. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study
  248. Abstinence Time and Its Impact on Basic and Advanced Semen Parameters
  249. Author Reply
  250. Novel concepts in male factor infertility: clinical and laboratory perspectives
  251. Oxidation-reduction potential (ORP) of spermatozoa selected for intracytoplasmic sperm injection (ICSI) after exposure to polyvinylpyrrolidone (PVP) and hyaluronic acid (HA)
  252. Cigarette smoking and semen quality: a new meta-analysis examining the effect of the 2010 world health organization laboratory methods for the examination of human semen
  253. Should we evaluate and treat sperm DNA fragmentation?
  254. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept
  255. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay using bench top flow cytometer for evaluation of sperm DNA fragmentation in fertility laboratories: protocol, reference values, and quality control
  256. Outcome of assisted reproductive technology in men with treated and untreated varicocele: systematic review and meta-analysis
  257. A systematic review of clinical practice guidelines and best practice statements for the diagnosis and management of varicocele in children and adolescents
  258. Outcome of varicocele repair in men with nonobstructive azoospermia: systematic review and meta-analysis
  259. Novel insights into the pathophysiology of varicocele and its association with reactive oxygen species and sperm DNA fragmentation
  260. Bibliometrics: tracking research impact by selecting the appropriate metrics
  261. Effect of varicocele on semen characteristics according to the new 2010 World Health Organization criteria: a systematic review and meta-analysis
  262. Summary evidence on the effects of varicocele treatment to improve natural fertility in subfertile men
  263. Specialized sperm function tests in varicocele and the future of andrology laboratory
  264. Varicocele and male infertility: current concepts and future perspectives
  265. Afterword to varicocele and male infertility: current concepts and future perspectives
  266. Implementation of cleanroom technology in reproductive laboratories: the question is not why but how
  267. Air quality control in the ART laboratory is a major determinant of IVF success
  268. Establishing a quality management system in a fertility center: experience with ISO 9001
  269. Varicocele and Male Infertility
  270. Association Between Varicocele and Infertility
  271. Cost-Effectiveness of Varicocele Treatment
  272. Definitions and Epidemiology
  273. Effect of Varicocele Treatment
  274. Guidelines and Best Practice Statements for the Evaluation and Management of Infertile Adult and Adolescent Males with Varicocele
  275. Origin and Pathophysiology
  276. Subclinical Varicocele
  277. Treatment Modalities
  278. Varicocele Classification
  279. Varicocele and Azoospermia
  280. Varicocele in Adolescents
  281. Comparison of reproductive outcome in oligozoospermic men with high sperm DNA fragmentation undergoing intracytoplasmic sperm injection with ejaculated and testicular sperm
  282. Pregnancy and birth after intracytoplasmic sperm injection with normal testicular spermatozoa in a patient with azoospermia and tail stump epididymal sperm
  283. A systematic review of recent clinical practice guidelines and best practice statements for the evaluation of the infertile male
  284. Percutaneous epididymal sperm aspiration as a method for sperm retrieval in men with obstructive azoospermia seeking fertility: operative and laboratory aspects
  285. Diagnostic accuracy of sperm DNA degradation index (DDSi) as a potential noninvasive biomarker to identify men with varicocele-associated infertility
  286. RE: Clinical relevance of routine semen analysis and controversies surrounding the 2010 World Health Organization criteria for semen examination
  287. Clinical management of infertile men with nonobstructive azoospermia
  288. Cervical Hostility and Vaginal pH in Females with Unexplained Infertility
  289. Controversies Surrounding the 2010 World Health Organization Cutoff Values for Human Semen Characteristics and Its Impact on Unexplained Infertility
  290. Definitions and Relevance of Unexplained Infertility in Reproductive Medicine
  291. Efficacy, efficiency and effectiveness of gonadotropin therapy for infertility treatment
  292. Genetic Basis of Unexplained Male Infertility
  293. Gonadotropin in Assisted Reproduction: An Evolution Perspective
  294. Impact of Mutations and Polymorphisms of Gonadotrophins and Their Receptors on the Outcome of Controlled Ovarian Stimulation
  295. Insights into the role of cervical mucus and vaginal pH in unexplained infertility
  296. List of Contributors
  297. Unexplained Infertility
  298. Role and Significance of Sperm Function in Men with Unexplained Infertility
  299. Sperm Physiology and Assessment of Spermatogenesis Kinetics In Vivo
  300. The Role of LH in Controlled Ovarian Stimulation
  301. Engaging Practicing Gynecologists in the Management of Infertile Men
  302. Effect of mobile telephones on sperm quality: A systematic review and meta-analysis
  303. Effectiveness of sperm washing by discontinuous density gradient centrifugation to remove antibodies bound to sperm membrane
  304. Clinical relevance of routine semen analysis and controversies surrounding the 2010 World Health Organization criteria for semen examination
  305. A translational medicine appraisal of specialized andrology testing in unexplained male infertility
  306. Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech
  307. Diagnostic accuracy of sperm chromatin dispersion test to evaluate sperm deoxyribonucleic acid damage in men with unexplained infertility
  308. Chapter-06 Male Infertility: When and How to Start the Evaluation?
  309. Shedding Light on the Controversy Surrounding the Temporal Decline in Human Sperm Counts: A Systematic Review
  310. Effectiveness of sperm washing by discontinuous density gradient centrifugation to remove antibodies bound to the sperm membrane
  311. Comparison of sperm retrieval and reproductive outcome in azoospermic men with testicular failure and obstructive azoospermia treated for infertility
  312. Re: Sperm retrieval rates and intracytoplasmic sperm injection outcomes for men with non-obstructive azoospermia and the health of resulting offspring
  313. Sperm chromatin dispersion (SCD) test identifies more spermatozoa with DNA damage than the TUNEL assay in men with unexplained infertility
  314. Sperm retrieval success and reproductive potential of azoospermic men undergoing sperm injection, but not the neonatal outcomes of babies born, are associated to the type of azoospermia
  315. Laser-assisted intracytoplasmic sperm injection (LA-ICSI) is safe and less traumatic than conventional ICSI
  316. Individualization of controlled ovarian stimulation using anti-mullerian hormone as a biomarker of ovarian response maximizes the beneficial effects of treatment and minimizes complication and risks
  317. Microdissection Testicular Sperm Extraction (micro-TESE) as a Sperm Acquisition Method for Men with Nonobstructive Azoospermia Seeking Fertility: Operative and Laboratory Aspects
  318. Characterisation of a subpopulation of sperm with massive nuclear damage, as recognised with the sperm chromatin dispersion test
  319. Hypogonadotropic Hypogonadism Revisited
  320. A comprehensive review of genetics and genetic testing in azoospermia
  321. An update on sperm retrieval techniques for azoospermic males
  322. Predictive factors for sperm retrieval and sperm injection outcomes in obstructive azoospermia: Do etiology, retrieval techniques and gamete source play a role?
  323. Reproductive outcomes, including neonatal data, following sperm injection in men with obstructive and nonobstructive azoospermia: case series and systematic review
  324. The azoospermic male: current knowledge and future perspectives
  325. PESA/TESA/TESE Sperm Processing
  326. Quality Management in ART Clinics
  327. Varicocele
  328. Surgical Treatment for Male Infertility
  329. Implementation of air quality control in reproductive laboratories in full compliance with the Brazilian Cells and Germinative Tissue Directive
  330. Reproductive Potential of Men with Obstructive Azoospermia Undergoing Percutaneous Sperm Retrieval and Intracytoplasmic Sperm Injection According to the Cause of Obstruction
  331. A clinical appraisal of the genetic basis in unexplained male infertility
  332. Micro-dissection testicular sperm extraction as an alternative for sperm acquisition in the most difficult cases of Azoospermia: Technique and preliminary results in India
  333. Insight into oxidative stress in varicocele-associated male infertility: part 2
  334. Insight into oxidative stress in varicocele-associated male infertility: part 1
  335. Brazil
  336. Defining What Reproductive Laboratories Do
  337. Ensuring that Reproductive Laboratories Provide High-Quality Services
  338. Explaining How Reproductive Laboratories Work
  339. Introduction to Quality Management in ART Clinics
  340. The Role of Reproductive Laboratories in the ART Clinic
  341. Unexplained Male infertility: diagnosis and Management
  342. Computer-assisted objective evaluation of sperm-containing seminiferous tubule in testicular sperm retrievals
  343. Nuclear status assessment of human embryos on day 2: a powerful tool in IVF cycles for embryo transfer selection
  344. Impact of the new Brazilian law in the reduction of multiple pregnancies
  345. Editorial Comment
  346. What every gynecologist should know about male infertility: an update
  347. Varicocele
  348. Surgical Treatment for Male Infertility
  349. Evaluation and Diagnosis of Male Infertility
  350. Surgical Management of Male Infertility
  351. PESA/TESA/TESE Sperm Processing
  352. Chapter-05 Semen Preparation: Ejaculated Sperm for ICSI
  353. Chapter-06 Semen Preparation: Sperm Extraction for ICSI
  354. A Critical Appraisal on the Role of Varicocele in Male Infertility
  355. Critical Appraisal of World Health Organization's New Reference Values for Human Semen Characteristics and Effect on Diagnosis and Treatment of Subfertile Men
  356. Laboratory handling of epididymal and testicular spermatozoa: What can be done to improve sperm injections outcome
  357. Sperm retrieval techniques for assisted reproduction
  358. Impact of the New WHO Guidelines on Diagnosis and Practice of Male Infertility
  359. What is New in the Clinical Assessment and Treatment of the Infertile Male
  360. Relationship of in Vitro Acrosome Reaction to Sperm Function: An Update
  361. Male Infertility and Assisted Reproductive Technology: Lessons from the IVF
  362. Microsurgical versus conventional single-biopsy testicular sperm extraction in nonobstructive azoospermia: a prospective controlled study
  363. Clinical efficacy, safety and tolerability of recombinant human chorionic gonadotropin to restore spermatogenesis and androgen production of hypogonadotropic hypogonadal men
  364. Quality of life and menopausal and sexual symptoms in gynecologic cancer survivors
  365. Unexplained male infertility
  366. Chromosomal and molecular abnormalities in a group of Brazilian infertile men with severe oligozoospermia or non-obstructive azoospermia attending an infertility service
  367. Sperm retrieval techniques
  368. Novel concepts in male infertility
  369. An update on the clinical assessment of the infertile male
  370. Surgical treatment of male infertility in the era of intracytoplasmic sperm injection - new insights
  371. Clinical Outcome of Intracytoplasmic Sperm Injection in Infertile Men With Treated and Untreated Clinical Varicocele
  372. Success of percutaneous sperm retrieval and intracytoplasmic sperm injection (ICSI) in obstructive azoospermic (OA) men according to the cause of obstruction
  373. Sperm retrieval rates (SRR) in nonobstructive azoospermia (NOA) are related to testicular histopathology results but not to the etiology of azoospermia
  374. Reproductive potential of azoospermic men undergoing intracytoplasmic sperm injection is dependent on the type of azoospermia
  375. Editorial Comment
  376. A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection
  377. Editorial Comment
  378. Resistance of human spermatozoa to cryoinjury in repeated cycles of thaw-refreezing
  379. Laparoscopic Orchiectomy
  380. Re: sperm defect severity rather than sperm source is associated with lower fertilization rates after intracytoplasmic sperm injection
  381. Sperm defect severity rather than sperm source is associated with lower fertilization rates after intracytoplasmic sperm injection
  382. Influence of antisperm antibodies in the semen on intracytoplasmic sperm injection outcome
  383. Lower doses of recombinant follicle stimulating hormone are required per live birth as compared to menotropins in intracytoplasmic sperm injection cycles
  384. Comparison of two systems to culture human embryos up to day 3: a prospective randomized study
  385. Influence of the cumulus cells exposed to exogenous luteinizing hormone (LH) activity during ovarian stimulation on human embryo development and intracytoplasmic sperm injection (ICSI) outcomes
  386. Limiting the number of oocytes to be fertilized in vitro can dramatically decrease the ability of men with severe male factor infertility to have children
  387. Effects of pentoxifylline treatment before freezing on motility, viability and acrosome status of poor quality human spermatozoa cryopreserved by the liquid nitrogen vapor method
  388. Evaluation of acrosomal status and sperm viability in fresh and cryopreserved specimens by the use of fluorescent peanut agglutinin lectin in conjunction with hypo-osmotic swelling test
  389. Author reply
  390. P-594
  391. P-769
  392. P-593
  393. P-588
  394. Recovery of spermatogenesis after microsurgical subinguinal varicocele repair in azoospermic men based on testicular histology
  395. Acrosome Integrity and Agonist-Induced Acrosome Reaction Rate After Stimulation by Varying Concentrations of a Specific Inhibitor of cGMP Phosphodiesterase Type-5 (Sildenafil) in Normozoospermic Specimens
  396. Feasibility of refreezing human spermatozoa through the technique of liquid nitrogen vapor
  397. Control of air pollution in assisted reproductive technology laboratory and adjacent areas improves embryo formation, cleavage and pregnancy rates and decreases abortion rate: Comparison between a class 100 (ISO 5) and a class 1.000 (ISO 6) cleanroom f...
  398. Sperm defect severity rather than sperm source is associated with lower fertilization rates after intracytoplasmic sperm injection
  399. Intracytoplasmic sperm injection: optical magnification during sperm selection and microinjection affects fertilization, cleavage, and pregnancy rates
  400. Effects of semen thaw-refreeze by standard vapor freezing method on human sperm motility, viability and morphology
  401. Sperm kinematics of normozoospermic specimens after stimulation by varying concentrations of a specific inhibitor of CGMP phosphodiesterase type-5 (Sildenafil)
  402. Effects of the technique of cryopreservation and dilution/centrifugation after thawing on the motility and vitality of spermatozoa of oligoasthenozoospermic men
  403. Lack of standardization in performance of the semen analysis among laboratories in the United States
  404. Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: a prospective study
  405. Predictive value of testicular histology in secretory azoospermic subgroups and clinical outcome after microinjection of fresh and frozen-thawed sperm and spermatids
  406. Sperm aneuploidy rates in younger and older men
  407. Can Varicocelectomy Significantly Change The Way Couples Use Assisted Reproductive Technologies?
  408. The Risk of Major Birth Defects after Intracytoplasmic Sperm Injection and in Vitro Fertilization
  409. Long-term outcomes of elective human sperm cryostorage
  410. Improvement in motion characteristics and acrosome status in cryopreserved human spermatozoa by swim-up processing before freezing
  411. RECOVERY OF SPERMATOGENESIS AFTER MICROSURGICAL VARICOCELE REPAIR IN AZOOSPERMIC MEN IS RELATED TO TESTICULAR HISTOLOGY
  412. Cryopreservation of human spermatozoa with pentoxifylline improves the post-thaw agonist-induced acrosome reaction rate
  413. TRANSURETHRAL RESECTION OF PARTIALLY OBSTRUCTED EJACULATORY DUCTS
  414. TRANSURETHRAL RESECTION OF PARTIALLY OBSTRUCTED EJACULATORY DUCTS: SEMINAL PARAMETERS AND PREGNANCY OUTCOMES ACCORDING TO THE ETIOLOGY OF OBSTRUCTION
  415. Ureteroscopic Stone Removal in the Distal Ureter. Why Change?
  416. Ureteroscopic Stone Removal in the Distal Ureter. Why Change?
  417. Suitability of the hypo-osmotic swelling test for assessing the viability of cryopreserved sperm
  418. Antegrade endopyelotomy for pelvi‐ureteric junction obstruction in children
  419. Laparoscopic Pediatric Orchiectomy
  420. Comparative Study of the Fertility Potential of Men with only one Testis